SBIR / STTR #DHA26BZ01-NV004

SBIR Solicitation for Wearable Device to Detect Biomarkers and Treat Infections

This opportunity from the Defense Health Agency (DHA) seeks innovative medical technology solutions for military and dual-use civilian applications, with a focus on wearable devices for infection detection and treatment. - Government Buyer: - Defense Health Agency (DHA), SBIR Program Management Office - Department of the Air Force (DAF) also referenced for operational medicine applications - Products/Services Requested: - Development of a non-invasive wearable device to detect biomarkers and provide initial broad-spectrum treatment for viral and bacterial infections - Part number: DHA26BZ01-NV004 - Prototype development and testing (1-5 units) required in Phase II - Device must continuously monitor biomarkers via biosensors, operate in austere environments, and securely transmit data to medical personnel - Additional SBIR topics include: - Shelf-stable canine whole blood product or substitute (DHA26BZ01-NV001) - Traumatic brain injury detection and treatment for Military Working Dogs (DHA26BZ01-NV002) - Environmental exposure detection and decontamination for Military Working Dogs (DHA26BZ01-NV003) - Small molecule antifungal compounds for human use (DHA26BZ01-DV005) - Unique/Notable Requirements: - FDA approval targeted for many products - CMMC Level 1 required for Phase I, Level 2 for Phase II - Device must be suitable for military operational environments and have secure data transmission - Animal research approvals required for canine-related products - Dual-use potential for civilian healthcare - No specific OEMs or vendors are named; opportunity is open to small businesses for R&D proposals - Funding ranges: - Phase I: up to $300,000 for 6 months - Phase II: up to $1,400,000 for 24 months - Direct to Phase II available for select topics

Description

This solicitation seeks proposals for the development of a wearable device capable of detecting biomarkers and treating viral and bacterial infections. It is part of the Department of War (DoW) Small Business Innovation Research (SBIR) program for fiscal year 2026. The solicitation is open for Phase 1, Phase 2, and Phase 2S (SPII) proposals. Proposers must submit their proposals via the Defense SBIR/STTR Innovation Portal (DSIP) and follow the detailed instructions provided in the DoW SBIR solicitation and additional DHA-specific instructions. The solicitation aims to support medical technology innovations that enhance the survivability and operational effectiveness of military personnel.

View original listing